Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

AQB vs EVGN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AQB Captures Overall Composite Edge (44.6 HOLD vs 44.1 HOLD), While EVGN Leads 3–1 on Growth & Valuation Pillars

AQB Overall Winner 6-Pillar Tally: AQB 1 – 3 EVGN (2 Tie) Matrix Metrics: AQB 5 – 1 EVGN

As of Nov 17, 2026, AquaBounty Technologies, Inc. (AQB) captures the overall head-to-head institutional edge over Evogene Ltd. (EVGN) on higher Unified Composite conviction (44.6/100 HOLD vs. 44.1/100 HOLD) after splitting the core matrix 5–1 (led by Profitability & Quality), while EVGN wins 3–1 across the 6-pillar growth and valuation breakdown. AQB trades at $0.82 (N/M Forward P/E, 0.0% operating margin) versus EVGN at $0.34 (N/M Forward P/E, -858.2% operating margin).

  • Growth vs. Quality Trade-Off: AQB earns the overall head-to-head edge with a stronger Unified Composite Score (44.6/100 HOLD vs. EVGN 44.1/100 HOLD) and 0.93β · 117% Vol risk profile, whereas EVGN leads top-line expansion (-60.7% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: AQB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.5); meanwhile EVGN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 44.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AQB vs EVGN
AQB NASDAQ Head-to-Head Winner
AquaBounty Technologies, Inc.
Fishing, Hunting And Trapping
$0.82
+2.01% 1D
Market Cap $9.7M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.93β · 117% Vol
Unified Composite Score
44.6 / 100 HOLD
Tech 33.0 Fund 49.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.5%), weak momentum, RSI 37
RSI-14: 37.5 · SMA20: $1.04 · SMA50: $1.03
EVGN NASDAQ
Evogene Ltd.
Agricultural Chemicals
$0.34
-13.17% 1D
Market Cap $6.0M
TTM Revenue $1.7M
Forward P/E N/M
Beta / 30D Vol 1.37β · 138% Vol
Unified Composite Score
44.1 / 100 HOLD
Tech 42.0 Fund 44.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -17.2%), weak momentum, RSI 44
RSI-14: 44.5 · SMA20: $0.36 · SMA50: $0.40

6-Pillar Scorecard Institutional Category Breakdown (AQB 1 – 3 EVGN)

Columns: Metric · AQB · EVGN
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale EVGN
Revenue Growth (YoY) -93.5% -60.7%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A $1.7M
Market Cap $9.7M $6.0M
3. Profitability & Quality AQB
Gross Margin N/A -67.6%
Operating Margin 0.0% -858.2%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -68.9% -182.8%
4. Balance Sheet & Cash Flow EVGN
Cash Generation (TTM) -$7.2M -$11M
Cash Flow Margin N/A N/A
Net Cash / Leverage $0.19 Book/Sh · -68.9% ROE $6.5M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning EVGN
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Farm Products Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AQB (5) vs EVGN (1)
Institutional Metric AQB EVGN Criterion Row Edge
Market Capitalization
Scale
$9.7M $6.0M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-93.5% -60.7% Higher Growth EVGN
Operating Margin (TTM)
Profitability
0.0% -858.2% Higher Margin AQB
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-68.9% -182.8% Higher ROE AQB
52-Week Range Position
Momentum
11% ($1–$2) 9% ($0–$1) Stronger Trend AQB
Beta / 30D Volatility
Risk Regime
0.93β · 117% Vol 1.37β · 138% Vol Lower Realized Risk AQB
Unified Institutional Score
Composite Signal
44.6 / 100 (HOLD) 44.1 / 100 (HOLD) Higher Composite AQB
Trailing 12M Revenue (USD)
Operating Scale
N/A $1.7M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A -67.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$7.2M ($0.19 Book/Sh · -68.9% ROE) -$11M ($6.5M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EVGN +13.79 pp
AQB: -21.37% · EVGN: -7.58%
3M Horizon AQB +4.89 pp
AQB: -38.51% · EVGN: -43.4%
6M Horizon AQB +32.92 pp
AQB: -21.37% · EVGN: -54.29%
1Y Horizon AQB +48.32 pp
AQB: -23.57% · EVGN: -71.89%

Financial Trajectory Multi-Year Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period AQB Revenue EVGN Revenue AQB Op. Margin EVGN Op. Margin Margin Leader
FY2021 $0M N/A -1883.0% N/A AQB
FY2022 $0M N/A -711.6% N/A AQB
FY2023 $0M N/A -552.9% N/A AQB
Q1 '25 N/A $10M N/A -129.2% EVGN
Q1 '26 N/A $0M N/A -943.1% EVGN
Q2 '25 N/A $0M N/A -347.4% EVGN
Q3 '25 N/A $0M N/A -873.1% EVGN
Q4 '25 N/A $0M N/A -1659.9% EVGN

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AQB BREAKDOWN
69d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AQB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
EVGN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact EVGN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AQB Moat Profile Cyclical / Execution-Driven Positioning
Farm Products Operator
Competes within the Farm Products value chain with $9.7M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
EVGN Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $6.0M market capitalization and -858.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AQB vs EVGN Key Questions & Quantitative Answers

As of Nov 17, 2026, AquaBounty Technologies, Inc. (AQB) captures the overall head-to-head institutional edge over Evogene Ltd. (EVGN) on higher Unified Composite conviction (44.6/100 HOLD vs. 44.1/100 HOLD) after splitting the core matrix 5–1 (led by Profitability & Quality), while EVGN wins 3–1 across the 6-pillar growth and valuation breakdown. AQB trades at $0.82 (N/M Forward P/E, 0.0% operating margin) versus EVGN at $0.34 (N/M Forward P/E, -858.2% operating margin). Growth vs. Quality Trade-Off: AQB earns the overall head-to-head edge with a stronger Unified Composite Score (44.6/100 HOLD vs. EVGN 44.1/100 HOLD) and 0.93β · 117% Vol risk profile, whereas EVGN leads top-line expansion (-60.7% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: AQB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.5); meanwhile EVGN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 44.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

EVGN leads the Growth & Scale pillar: AQB posts -93.5% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with EVGN at -60.7% YoY revenue growth and +0.0% YoY earnings growth on $1.7M TTM revenue (-67.6% gross margin, -858.2% operating margin). Across the 8-period historical trajectory (FY2021 to Q4 '25), AQB cumulative revenue shifted N/A while EVGN shifted N/A. In operating R&D and SG&A reinvestment, AQB deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for EVGN.

AQB and EVGN trade at balanced relative valuation multiples. AQB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas EVGN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AQB (-68.9% ROE) versus EVGN (-182.8% ROE) capital efficiency.

In options market volatility and institutional positioning, AQB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.93β · 117% Vol realized risk). By comparison, EVGN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.37β · 138% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.